Target intelligence / Profile preview

RNA, U2 small nuclear 64, pseudogene (RNU2-64P)

Target: RNU2-64P
Molecular classification: Other, Pseudogene

Overview

RNU2-64P is a member of the U2 small nuclear RNA (snRNA) pseudogene family in humans[1][3]. While canonical U2 snRNAs are essential components of the spliceosome, playing a pivotal role in pre-mRNA splicing and containing numerous conserved modifications critical for function[2][4], pseudogenes such as RNU2-64P are considered non-functional genetic elements that resemble functional RNA genes but typically do not encode active products[3][1]. There is no evidence that RNU2-64P is transcribed or has biological activity, nor is it implicated as a receptor, enzyme, or therapeutic drug target.

Other names: RNU2-64P

Beyond the preview

Go deeper on RNA, U2 small nuclear 64, pseudogene (RNU2-64P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 64, pseudogene (RNU2-64P).

Explore the full profile